Skip to main content

2 Result(s)

within Hidemi Kiyota Remove this filter

and

  1. No Access

    Article

    Phase I and pharmacokinetic study of gefitinib and S-1 combination therapy for advanced adenocarcinoma of the lung

    A phase I dose-escalation study was performed to investigate the safety and pharmacokinetics of the combination of S-1 and gefitinib in patients with pulmonary adenocarcinoma who had failed previous chemotherapy.

    Hidemi Kiyota, Isamu Okamoto, Masayuki Takeda… in Cancer Chemotherapy and Pharmacology (2013)

  2. No Access

    Article

    High-dose dexamethasone plus antihistamine prevents colorectal cancer patients treated with modified FOLFOX6 from hypersensitivity reactions induced by oxaliplatin

    Oxaliplatin is a third-generation platinum compound and a key agent for the management of colorectal cancer. Patients treated with oxaliplatin are at risk for hypersensitivity reactions. We designed a modified...

    Yasuhiro Kidera, Taroh Satoh, Shinya Ueda… in International Journal of Clinical Oncology (2011)